Key facts
- This page summarizes Eric E. Poma's Form 4 filing for Molecular Templates, Inc..
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 25 Jan 2024, 17:32.
Eric E. Poma - 23 Jan 2024 Form 4 Insider Report for Molecular Templates, Inc.
- Signature
- /s/ Eric E. Poma
- Issuer symbol
- N/A
- Transactions as of
- 23 Jan 2024
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 25 Jan 2024, 17:32:39 UTC
- Previous filing
- 17 Feb 2023
- Next filing
- 25 Apr 2025
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Eric E. Poma filed Form 4 for Molecular Templates, Inc. on 25 Jan 2024.
Change
- Previous filing in this sequence was filed on 17 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
MTEM
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +23,333
- Change %
- Price
- $0.000000
- Shares after
- 23,333
- Date
- 23 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 23,333
- Exercise price
- $3.55
- Footnotes
- F1, F2
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023. |
| F2 | 25% of the total number of shares subject to the option shall vest on January 23, 2025, and the remaining 75% shall vest in thirty-six (36) equal monthly installments, subject to the reporting person's continued service through the applicable vesting dates. |
Remarks:
Chief Executive Officer and Chief Scientific Officer